Private Advisor Group, LLC Neurocrine Biosciences Inc Transaction History

Private Advisor Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$96.16 - $135.15 $98,083 - $137,853	-1,020 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$85.09 - $130.36 $86,791 - $132,967	1,020 New	1,020 $124,000
Q4 2019 Feb 10, 2020	SELL	$86.8 - $118.57 $168,912 - $230,737	-1,946 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $163,113 - $197,519	1,946 New	1,946 $202,000
Q4 2018 Feb 11, 2019	SELL	$68.32 - $124.36 $196,693 - $358,032	-2,879 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$98.88 - $125.85 $284,675 - $362,322	2,879 New	2,879 $354,000

653

96.5M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.